ArticleMedical oncology (Northwood, London, England)2022

Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model.

Ying Yuan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.